Impact of ELX/TEZ/IVA on Patients With Cystic Fibrosis (TRAJECTORY)
We have recently commenced a new study in conjunction with with Vertex Pharmaceuticals Incorporated and Cardiff and Vale University...
top of page
Search
Glenn Hearson
- Oct 29, 2021
Experts from the University of Nottingham to develop new treatments for cystic fibrosis infections
Experts from the University of Nottingham have joined a Strategic Research Centre as part of a new international collaboration led by...
66
Glenn Hearson
- Aug 11, 2021
CF STORM a ground-breaking trial to assess management of CF patients daily healthcare routines
Dr Helen Barr of the NIHR Nottingham Biomedical Research Centre, will shortly commence recruitment into the CF STORM study at NUH...
70
Glenn Hearson
- Jan 19, 2017
sTREM-1 is elevated in cystic fibrosis and correlates with proteases
sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) is a novel inflammatory marker that may be of clinical use in cystic fibr
38
Glenn Hearson
- Sep 11, 2016
Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelia
Airway epithelial cells in cystic fibrosis (CF) overexpress Interleukin 8 (CXCL8) through poorly defined mechanisms. CXCL8 transcription is
16
Glenn Hearson
- Jan 10, 2016
Glutamine supplementation in cystic fibrosis
Pulmonary infection and malnutrition in cystic fibrosis are associated with decreased survival. Glutamine has a possible anti-microbial effe
55
Glenn Hearson
- Nov 28, 2015
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
Pseudomonas aeruginosa produces quorum sensing signal molecules that are potential biomarkers for infection.A prospective study of 60 cystic
18
bottom of page